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Coagulation Changes in Elective Surgery and Trauma
ALAN E. SEYFER, M.D.,* ANTHONY V. SEABER,t FREDERICK A. DOMBROSE, PH.D.,4 JAMES R. URBANIAK, M.D.t
Although antithrombin-3 (AT-3), a naturally-occurring in-
hibitor of thrombin, has been associated with a variety of
thrombotic disorders, it has not been studied in surgery and
trauma. Three groups of patients were studied: Group I (20
patients) who underwent elective surgery; Group II (ten
patients) who sustained moderate trauma; Group III (ten
patients) who sustained severe trauma. Hypercoagulability
panels were run preoperatively, intraoperatively, and post-
operatively. Nine units of banked blood were also tested.
The coagulation pattern changed during the stress, becoming
hypercoagulable in proportion to the stress endured by the
patient. In the severe trauma group, AT-3 fell significantly
(p s 0.002) in all patients, indicating extreme hyperco-
agulability. Three of these patients sustained thrombosis and
loss of the involved extremity. The banked blood was found
to be hypercoagulable. It appears that patients who sustain
severe trauma, have multiple transfusions, and major opera-
tive procedures are at increased risk of developing post-
operative thrombotic complications, including loss of limb.
IN RECENT YEARS, it has become apparent that the
rapid and complex sequence of events resulting in a
stable clot is balanced by a vanguard of circulating
antagonists which are extremely efficient in limiting and
localizing coagulation. In effect, they are responsible
for maintaining the fluidity of the blood.
The presence of a naturally-occurring inhibitor of
thrombin was first observed by Schmidt in 1892. This
progressive inactivation ofthrombin was ascribed to an
"antithrombin." Virchow, another early investigator
of coagulation, drew attention to the triad of stasis,
intimal injury, and hypercoagulability (Fig. 1). His
observations are as pertinent today as in 1846. If any
two components of the triangle are present, clotting
ensues. Although stasis and intimal damage have been
studied in the past, an understanding of the so-called
hypercoagulable state has been incomplete. More and
more evidence points to the existence of a delicate
balance between stimuli that activate coagulation and
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protective mechanisms that counteract their effect
the antithrombins." 2 Certainly, abnormalities in either
system are potentially devastating.
Since the time of Schmidt and Virchow, six different
antithrombin activities in blood have been described
(Table 1). Of these, antithrombin-3 (AT-3), with its
active alpha-2 globulin portion, appears to be, clinically,
the most important naturally-occurring plasma inhibitor
of thrombin.3'4
Low levels of AT-3 have been implicated in a variety
of thrombotic disorders, including those associated
with contraceptive agents,5'6 mesenteric venous throm-
bosis,78 postoperative myocardial infarction,9"0 and
venous thromboembolism.9"",12
Although no AT-3 studies have been done with
regard to trauma, the possibility of a hypercoagulable
state secondary to the stress of an operative pro-
cedure has been investigated. The results, however, are
conflicting, with some investigators reporting a fall in
AT-3,'214 others finding no significant change,'5'16 and
still others reporting a somewhat divided picture.'7
Closer scrutiny reveals that these studies may have
been limited by excessive variables, long intervals be-
tween blood sampling, and the absence of intra-
operative measurements.
The present study was designed to assess the existence
of any change in coagulation during operative stress or
trauma (or both), with particular reference to hyper-
coagulability.
Materials and Methods
Three groups of patients were studied prospectively.
Group I consisted of 20 patients, and ranged in age
from 3-50 years (mean: 19.7). These patients were
selected at random. They underwent routine, elective
orthopedic extremity procedures for which no blood
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transfusions were administered. Group I patients were
receiving no medications, and had no personal or
familial history of medical illness. Blood samples were
obtained from a high-flow vessel (femoral vein) by
plastic syringe, placed in liquid sodium citrated tubes,
and separated, quick-frozen, and stored within minutes
of venipuncture. All samples were drawn by one
individual before, during (two hours into the procedure),
and 24 hours after operation. The following tests were
performed: antithrombin-3 activity assay, antithrombin-3
quantification by radial immunodiffusion, available
plasminogen, thrombin clotting time, prothrombin
time, partial thromboplastin time, and activated partial
thromboplastin time.
Group II consisted of ten patients who had sustained
moderately-severe isolated hand trauma, consisting of
replantation or revascularization of one or more digits.
The patients ranged in age from 14-56 years (mean:
28.3). No patient required blood tranfusion. These
patients were healthy, except for this traumatic episode.
The same tests and sampling patterns as for Group I
patients were observed.
Group III consisted often patients who had sustained
isolated, severe, upper (eight patients) or lower (two
patients) extremity trauma, which required replanta-
tion or revascularization of a severed arm or leg. The
patients ranged in age from 20-59 years (mean: 32.5).
FIG. 1. Virchow's triad (1846). If any two components are pres-
ent, clotting ensues.
TABLE 1. Classes of Antithrombins
Antithrombin Activity
I Refers to adsorption of thrombin to fibrin,
thus removing its activity
II Cofactor of heparin; possibly part of AT-3
molecule
III Irreversibly binds thrombin and possibly
other factors
IV Active during clotting (existence questionable)
V Present in certain disease states (weak)
VI Refers to activity of fibrin degradation products
These patients all received four or more blood transfu-
sions. In three patients, AT-3 was sampled from both
the patient and from the transfused blood. Samples
were not drawn before operation in certain instances,
due to emergent priorities or because they had received
blood en route, thereby nullifying their own con-
trol value.
Intraoperative and postoperative determinations
were normalized in standard fashion with respect
to the preoperative value, so that any change could
be seen as a percentage of deviation from the patient's
own normal pattern. Means, standard deviations, and
probability values were computed in standard fashion.
In addition, nine units of banked whole blood and
packed cells were assayed for AT-3 by the same
methods. The mean age of the blood was 13.6 days.
Results
In Group I, AT-3, available plasminogen, and PTT
levels fell in 16 of 20 patients, with thrombin clotting
time falling in ten of the 20 patients (Fig. 2). PT re-
mained normal in 18 patients and fell in two. All
values were reverting toward normal at 24 hours. Post-
operative convalescence was uneventful in all 20
patients.
In Group II, AT-3 fell in six of ten patients and
remained in the normal range in four patients (Fig. 3);
available plasminogen was depressed in seven patients.
The PT remained unchanged and the PTT, APTT and
thrombin clotting times were elevated as a result of
the administration of heparin during the vascular
repair procedure. One patient in this group sustained
a thrombosis and lost the replanted part.
In Group III AT-3 levels fell to less than 80% of
normal in all patients, with five decreasing to the 60%
range (Fig. 4). Four of these latter patients exhibited
clinical evidence of thrombosis within hours of the
operation, although initially there was no evidence of
compromise. Three of these patients lost the involved
extremity. Available plasminogen levels and thrombin

















Intro ape rotive 24 hrs. Postoperative
FIG. 2. The fall in AT-3 depicted here indicates that there is a trend
toward accelerated clotting during elective surgery.
clotting times were extremely low (25-40% of normal),
an indication of consumption of fibrinogen.
AT-3 levels were below normal range in six of nine
units of banked blood (mean: 76% of normal); three
units of blood were within the normal limits. In the
three patients sampled simultaneously, AT-3 levels
were low in both the patient and in the blood they
received. One of these patients lost an extremity due
to postoperative thrombosis. No correlation was noted
between the age of the blood and the levels of AT-3.
Discussion
The precipitous fall in AT-3 after severe trauma
noted in this study brings up several points of great
interest clinically. First, it may explain why some
severely-injured patients are beset with repeated
thrombosis. These patients (Group III) are at the limit
of their reserves, having sustained loss of blood, deple-
tion of coagulation factors, massive fluid and blood
replacement and a major vascular repair. They are
primed for intravascular coagulation and have, in




Preoperative Introoperative 24 hrs. Postoperative
FIG. 3. The depletion of AT-3 in response to moderate trauma and
surgery, although not significant, reflects a trend toward accelerated
thrombosis. The low level of AT-3 is still present at 24 hours after
operation.
Preoperative Introoperative 24 hrs Postoperative
FIG. 4. AT-3 levels are significantly depressed in the patients with
severe trauma. In addition, these patients exhibited a high incidence
of complications. Three in this group lost the involved extremity
secondary to thrombosis. The dotted line indicates a slower return to
normal, although only measured in three individuals at 24 hours
after operation. All patients in this group received four or more
units of banked blood.
triad (Fig. 1). It is not surprising, therefore, that
AT-3 levels are also depleted. In this setting, loss of
limb is a very real possibility-as demonstrated by
three of our patients.
Second, it appears that multiple blood transfusions
(four or more) may compound the risk of thrombosis.
In three of our patients AT-3 levels were extremely
low in both the banked blood and simultaneously
in the recipients of that blood. One of these individuals
was noted to have a thrombosis postoperatively and
ultimately lost the involved arm. The patients, ofcourse,
urgently required replacement of red cell mass. To
what degree thrombosis was augmented by the banked
blood is not known. However, it is of interest because
of the complication that followed. Although certain
labile coagulation factors are known to lose their
activity during storage, it may be that inhibitors of clot-
ting are also changed and that, overall, the latter may
be of greater clinical importance.
Third, a spectrum is evident-ranging from the mild,
controlled trauma of elective surgery in which no
complications occur, to the massive injury and major
operation, in which postoperative thrombosis is a grave
risk. Within this range, there are corresponding changes
in the levels of AT-3. It appears that, as massive co-
agulation occurs, clotting factors are activated and
depleted rapidly. This activation exceeds the local
requirements-a phenomenon which is not altogether
unexpected, since the clotting enzymes are normally
present in great excess.4 As a result, the circulating
antithrombins combine with the activated coagulants in
order to neutralize their effect. In turn, these inhibitors
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antithrombins cannot keep up with the activated co-
agulants. At this point, uncontrollable thrombosis
becomes a possibility. That the level of tolerance
is different in each individual is demonstrated by the
fact that six of the severe trauma patients exhibited
extremely low levels of AT-3 and yet recovered with-
out complication. It is also of interest to note the
similarities between the results of Group III and those
in disseminated intravascular coagulation (DIC). It is
known that shock can lead to DIC and that AT-3
levels are significantly decreased in this syndrome.18
Also, available plasminogen levels and thrombin
clotting times were extremely low, reflecting continuing
fibrinogen depletion. Therefore it is possible that these
patients were in a very early stage of DIC.
Finally, it should be mentioned that these changes in
coagulation can occur rapidly, especially in severe
trauma. Three of these latter patients exhibited a sharp
decline in AT-3 over a period of only two hours.
During that time, they had received multiple trans-
fusions.
Although the treatment of hypercoagulability is not
established, it is known that low-dose heparin therapy
can abolish decreases in AT-3 in certain patients who
undergo elective surgery. 12 In the acute situation,
consideration should be given to replenishment of co-
agulation factors and AT-3. Fresh frozen plasma can
be very useful in this regard.
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